Background: It is estimated that 1 in 300-500 people in the United States are affected by hereditary breast and ovarian cancer syndrome (HBOC), a genetic condition that predisposes individuals to developing cancer in various tissues. From Angelina Jolie’s diagnosis as a BRCA mutation carrier to the Supreme Court ruling on gene patents, HBOC has received a great deal of attention in the media recently. However, the condition continues to be underdiagnosed and genetic services that can reduce risk and identify cancers earlier are often overlooked. Using the numerous screening tools, guidelines and recommendations currently available for HBOC would save lives.

Appropriate management of individuals with HBOC can significantly reduce morbidity and mortality in this population. Therefore, an integrated public health approach focused on the identification of individuals at risk for HBOC is critical to impacting health outcomes of individuals and families.

Objective: This webinar will highlight real world examples of successful programs that address HBOC, describe available screening tools and other resources related to HBOC and provide patient perspectives on the importance of identifying individuals and families with HBOC.

Audience: Public health professionals, primary care clinicians, oncologists, and other healthcare professionals involved in cancer, genetics or chronic disease prevention are encouraged to participate in this webinar.

свернуть